3
Announcements
Trials
Browse
Landscape
Status
Enrolling by invitation
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
14
Other solid neoplasm
14
Gynecologic
7
Gastrointestinal
7
Genitourinary
3
Breast
3
Sarcoma
2
Endocrine
2
NET
1
Head & Neck
1
Dermatologic
1
CNS
1
Conditions
Squamous Cell Carcinoma of Head and Neck
140
Head and Neck Neoplasms
114
Carcinoma, Non-Small-Cell Lung
49
Thyroid Neoplasms
42
Melanoma
36
Nasopharyngeal Carcinoma
35
Mouth Neoplasms
35
Ovarian Neoplasms
30
Breast Neoplasms
30
Oropharyngeal Neoplasms
29
Colorectal Neoplasms
29
Neoplasm Metastasis
26
Uterine Cervical Neoplasms
24
Lung Neoplasms
22
Neoplasms
20
Carcinoma, Squamous Cell
20
Carcinoma, Renal Cell
20
Carcinoma
19
Stomach Neoplasms
18
Pancreatic Neoplasms
17
Prostatic Neoplasms
16
Esophageal Neoplasms
16
Endometrial Neoplasms
16
Triple Negative Breast Neoplasms
15
Laryngeal Neoplasms
15
Sarcoma
14
Urinary Bladder Neoplasms
13
Hypopharyngeal Neoplasms
12
Carcinoma, Transitional Cell
12
Salivary Gland Neoplasms
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Mesothelioma
×
Head & Neck
×
30 days
×
Clear all
NCT06885424
2026-05-20
DESCENT-1
A2 Biotherapeutics Inc.
Enrolling by invitation
400 enrolled